Natalizumab for multiple sclerosis: a complicated treatment

被引:5
作者
Keegan, B. Mark [1 ]
机构
[1] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA
关键词
PLACEBO-CONTROLLED TRIAL; PATIENT SELECTION; RECOMMENDATIONS;
D O I
10.1016/S1474-4422(11)70150-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:677 / 678
页数:2
相关论文
共 8 条
[1]  
Clifford D, 2011, NEUROLOGY, V76, pA28
[2]   Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring [J].
Kappos, Ludwig ;
Bates, David ;
Hartung, Hans-Peter ;
Havrdova, Eva ;
Miller, David ;
Polman, Chris H. ;
Ravnborg, Mods ;
Houser, Stephen L. ;
Rudick, Richard A. ;
Weiner, Howard L. ;
O'Connor, Paul W. ;
King, John ;
Radue, Ernst Wilhelm ;
Yousry, Tarek ;
Major, Eugene O. ;
Clifford, David B. .
LANCET NEUROLOGY, 2007, 6 (05) :431-441
[3]   Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring [J].
Kappos, Ludwig ;
Bates, David ;
Edan, Gilles ;
Eraksoy, Mefkure ;
Garcia-Merino, Antonio ;
Grigoriadis, Nikolaos ;
Hartung, Hans-Peter ;
Havrdova, Eva ;
Hillert, Jan ;
Hohlfeld, Reinhard ;
Kremenchutzky, Marcelo ;
Lyon-Caen, Olivier ;
Miller, Ariel ;
Pozzilli, Carlo ;
Ravnborg, Mads ;
Saida, Takahiko ;
Sindic, Christian ;
Vass, Karl ;
Clifford, David B. ;
Hauser, Stephen ;
Major, Eugene O. ;
O'Connor, Paul W. ;
Weiner, Howard L. ;
Clanet, Michel ;
Gold, Ralf ;
Hirsch, Hans H. ;
Radue, Ernst-Wilhelm ;
Sorensen, Per Soelberg ;
King, John .
LANCET NEUROLOGY, 2011, 10 (08) :745-758
[4]   Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function [J].
Khatri, B. O. ;
Man, S. ;
Giovannoni, G. ;
Koo, A. P. ;
Lee, J. -C. ;
Tucky, B. ;
Lynn, F. ;
Jurgensen, S. ;
Woodworth, J. ;
Goelz, S. ;
Duda, P. W. ;
Panzara, M. A. ;
Ransohoff, R. M. ;
Fox, R. J. .
NEUROLOGY, 2009, 72 (05) :402-409
[5]   Natalizumab Drug Holiday in Multiple Sclerosis: Poorly Tolerated [J].
Killestein, Joep ;
Vennegoor, Anke ;
Strijbis, Eva M. ;
Seewann, Alexandra ;
van Oosten, Bob W. ;
Uitdehaag, Bernard M. J. ;
Polman, Chris H. .
ANNALS OF NEUROLOGY, 2010, 68 (03) :392-395
[6]   IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB? [J].
Lenhard, T. ;
Biller, A. ;
Mueller, W. ;
Metz, I. ;
Schoenberger, J. ;
Wildemann, B. .
NEUROLOGY, 2010, 75 (09) :831-833
[7]   MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS [J].
Miller, D. H. ;
Soon, D. ;
Fernando, K. T. ;
MacManus, D. G. ;
Barker, G. J. ;
Yousry, T. A. ;
Fisher, E. ;
O'Connor, P. W. ;
Phillips, J. T. ;
Polman, C. H. ;
Kappos, L. ;
Hutchinson, M. ;
Havrdova, E. ;
Lublin, F. D. ;
Giovannoni, G. ;
Wajgt, A. ;
Rudick, R. ;
Lynn, F. ;
Panzara, M. A. ;
Sandrock, A. W. .
NEUROLOGY, 2007, 68 (17) :1390-1401
[8]   A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis [J].
Polman, CH ;
O'Connor, PW ;
Havrdova, E ;
Hutchinson, M ;
Kappos, L ;
Miller, DH ;
Phillips, JT ;
Lublin, FD ;
Giovannoni, G ;
Wajgt, A ;
Toal, M ;
Lynn, F ;
Panzara, MA ;
Sandrock, AW .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :899-910